The implementation of prenatal and preconception carrier screening using genetic analysis could detect and prevent the disease, but the availability of simple and inexpensive technology for detecting mutations on the CFTR gene is a determining factor in the CF diagnosis. This evidence concerns the gene CFTR and cystic fibrosis.